StockNews.AI
CTLT
StockNews.AI
74 days

Asia-Pacific Pharmaceutical CMO Market Share Analysis, Trends and Growth Forecasts to 2030 Featuring Catalent, Recipharm, Jubilant Life Sciences and More

1. APAC CMO market projected to grow from $59.97B in 2025 to $91.18B by 2030. 2. China and India are leading the CMO growth with favorable policies and low costs. 3. Injectable drug demand is rising, focusing mostly on oncology treatments. 4. COVID-19 has disrupted supply chains, impacting raw material costs and inventory management. 5. Major pharmaceutical firms are increasingly outsourcing production to CMOs.

7m saved
Insight
Article

FAQ

Why Bullish?

The growth in the APAC CMO market presents significant opportunities for CTLT, especially if it adopts strategic partnerships or initiatives to leverage cost efficiencies and market demand.

How important is it?

The article outlines industry trends that align with CTLT's operational model and market expansion strategies in the pharmaceutical outsourcing space.

Why Long Term?

As the CMO sector expands through 2030, CTLT could benefit from the increased demand for contract manufacturing and the rise in oncology drug formulations, influencing revenue streams.

Related Companies

CATTMOPFEBAXLONN
Dublin, June 06, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Pharmaceutical Contract Manufacturing Organization - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025-2030)" report has been added to ResearchAndMarkets.com's offering. The Asia-Pacific Pharmaceutical Contract Manufacturing Organization (CMO) Market is poised for remarkable growth, advancing from an estimated USD 59.97 billion in 2025 to a forecasted USD 91.18 billion by 2030, reflecting a robust compound annual growth rate (CAGR) of 8.74% during this period. China's competitive edge in the CMO market is underscored by its low labor costs, tax incentives, and advantageous currency valuation, which enable pharmaceutical companies to significantly reduce manufacturing expenses. The country benefits from a workforce trained in Western standards, who are returning amid stringent immigration policies abroad. These dynamics, along with government support, have positioned China as a major pharmaceutical manufacturing hub. India, too, is capitalizing on the burgeoning CMO market, attracting Japanese pharmaceutical investments through favorable foreign direct investment policies. This strategic alignment is fostering partnerships that significantly bolster the domestic manufacturing landscape.Japan's CMO sector, although nascent, has observed a substantial 30% growth following regulatory changes that distinguish manufacturing from sales. Leading players include Bushu Pharmaceuticals and CMIC.Australia's pharmaceuticals face challenges due to pricing and reimbursement volatility, yet its geographical location near South Asian markets enhances its export potential.The COVID-19 pandemic, having originated in Wuhan, a vital pharmaceutical center, has affected global supply chains. This disruption necessitates strategic responses to inventory management, as China provides essential raw materials. Injectable Dose Formulations Lead Growth The demand for injectable drugs, driven by the need for rapid acting oncology treatments, underscores a significant opportunity within the market. These formulations promise higher returns due to therapeutic efficiency and swift action.Prolific late-stage clinical trials, chiefly in cancer therapies, are poised to amplify market growth, with anti-cancer drugs comprising nearly half of the developmental pipeline.Outsourcing of biologic formulations to CMOs is prevalent, as major pharmaceutical entities concentrate on the discovery and development of new drug modalities. India's Impactful CMO Market Share India leverages its vast manpower and regulatory approval to attract multinational pharmaceutical enterprises, enhancing its global footprint in drug manufacturing.Recent policies allowing certain drug studies without late-stage clinical trials lead to considerable cost savings, fortifying India's appeal for pharmaceutical production.The impact of the COVID-19 outbreak on India's sector is evident, with increased costs for APIs due to reliance on Chinese production. The APAC pharmaceutical CMO market shows a highly fragmented landscape. Large pharmaceutical firms are increasingly outsourcing production to CMOs, seeking cost efficiency and expertise. Vendors are expanding through strategic collaborations to enhance market share. Recent industry developments include expansions by Jubilant Biosys in India and Boehringer's capacity increase in China. Key Topics Covered1 INTRODUCTION1.1 Study Assumptions and Market Definition1.2 Scope of the Study2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY4 MARKET DYNAMICS4.1 Market Overview4.2 Industry Attractiveness - Porter's Five Forces Analysis4.3 Industry Value Chain Analysis4.4 Industry Policies4.5 Market Drivers4.5.1 Increasing Outsourcing Volume by Pharmaceutical Companies4.6 Market Restraints4.6.1 Increasing Lead Time and Logistics Costs4.6.2 Stringent Regulatory Requirements4.6.3 Capacity Utilization Issues Affecting the Profitability of CMOs4.7 Assessment of Impact of COVID-19 on the market5 TECHNOLOGY SNAPSHOT6 MARKET SEGMENTATION6.1 Service Type6.1.1 Active Pharmaceutical Ingredient (API) Manufacturing6.1.1.1 Small Molecule6.1.1.2 Large Molecule6.1.1.3 High Potency API (HPAPI)6.1.2 Finished Dosage Formulation (FDF) Development and Manufacturing6.1.2.1 Solid Dose Formulation6.1.2.2 Liquid Dose Formulation6.1.2.3 Injectable Dose Formulation6.1.3 Secondary Packaging6.2 Country6.2.1 China6.2.2 India6.2.3 Japan6.2.4 Australia6.2.5 Rest of Asia-Pacific7 COMPETITIVE LANDSCAPE7.1 Company Profiles7.1.1 Catalent Inc.7.1.2 Recipharm AB7.1.3 Jubilant Life Sciences Ltd.7.1.4 Thermo Fisher Scientific Inc. (Patheon Inc.)7.1.5 Boehringer Ingelheim Group7.1.6 Pfizer CentreSource (Pfizer Inc.)7.1.7 Aenova Group7.1.8 Famar SA7.1.9 Baxter Biopharma Solutions(Baxter International Inc.)7.1.10 Lonza Group8 INVESTMENT ANALYSIS9 FUTURE OF THE MARKET For more information about this report visit https://www.researchandmarkets.com/r/ktb1jq About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Related News